CINCINNATI, Ohio, March 31 -- The University of Cincinnati posted the following news:

* * *

Exploring GLP-1 drugs for Alzheimer's prevention

UC study uses anonymous real-world patient data to rate safety, effectiveness, affordability

By Tim Tedeschi, 513/556-5694, tedesctd@ucmail.uc.edu

Glucagon-like peptide-1 (GLP-1) drugs have surged in popularity due to their effect on the digestive system, helping patients manage Type 2 di . . .

Click here for more information about our products